Medicare Enrolled

Dr. Tracy Cannon-Smith, MD

Urology Physician · Arlington, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
5005 S COOPER ST STE 250, Arlington, TX 76017
8663678768
In practice since 2005 (20 years)
NPI: 1942297569 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cannon-Smith from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cannon-Smith? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cannon-Smith

Dr. Tracy Cannon-Smith is an urology physician in Arlington, TX, with 20 years in practice. Based on federal Medicare data, Dr. Cannon-Smith performed 7,524 Medicare services across 3,351 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cannon-Smith received a total of $29,165 from 52 pharmaceutical and/or device companies across 325 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cannon-Smith is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 14% volume in TX$ $29,165 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,524
Medicare services
Top 14% in TX for urology physician
3,351
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~376 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit2,800$5$14
Automated urinalysis739$2$5
Bladder ultrasound after voiding637$8$24
Office visit, established patient (30-39 min)545$91$281
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique282$69$288
Office visit, established patient (20-29 min)246$65$199
Yeast/candida DNA test188$34$304
Detection test by nucleic acid for herpes simplex virus, amplified probe technique188$34$176
Infectious disease DNA/RNA test188$34$112
New patient office visit (45-59 min)117$117$370
Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique94$34$80
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique94$34$80
Detection test by nucleic acid for herpes virus-6, amplified probe technique94$34$80
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique94$34$80
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique94$34$80
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique94$34$80
Complex measurement of pressure of urine flow in bladder with voiding pressure studies87$285$817
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings87$25$142
Insertion of device into abdomen with pressure and urine flow rate study87$153$432
Urinalysis, manual84$3$8
Electronic assessment of bladder emptying81$5$31
Basic metabolic blood panel70$8$19
Complete blood count (CBC), automated65$6$14
Injection procedure for imaging of bladder during voiding63$85$472
Review by radiologist of urinary bladder and urethra images with contrast and after passing urine63$83$233
Blood draw (venipuncture)58$6$13
Electronic analysis of implanted neurostimulator generator with simple spinal cord or peripheral nerve stimulator programming43$35$104
Diagnostic exam of bladder and urethra using an endoscope36$184$545
Simple change of bladder tube33$74$222
Exam with injections of chemical for destruction of bladder using an endoscope23$307$865
Simple bladder irrigation and/or instillation22$60$165
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional20$17$50
Creation of sling around urethra in female to control leakage18$377$1,635
Insertion of peripheral or gastric neurostimulator generator17$77$587
Injection of implant material beneath lining of bladder and/or urethra using an endoscope16$109$810
Insertion of sacral nerve neurostimulator electrode array15$231$1,728
Insertion of artificial material for pelvic floor defect14$194$562
Repair of pelvic ligaments through vagina14$369$1,578
Surgical repair of vaginal defect using an endoscope14$751$2,125
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$29,165
Total received (2018-2024)
Avg $4,166/year across 7 years
Top 9% in TX for urology physician
52
Companies
325
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,511 (49.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$12,343 (42.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,140 (7.3%)
Scientific / Research
Research funding and grants
$170 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,933
2023
$3,446
2022
$1,627
2021
$5,284
2020
$2,927
2019
$11,268
2018
$1,680

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Caldera Medical, Inc
$9,418
Axonics, Inc.
$6,085
Medtronic, Inc.
$4,525
Medtronic USA, Inc.
$3,843
Astellas Pharma US Inc
$947
Coloplast Corp
$416
Boston Scientific Corporation
$389
Valencia Technologies Corporation
$296
Janssen Biotech, Inc.
$233
Kerecis Limited
$224
Bayer Healthcare Pharmaceuticals Inc.
$209
AbbVie Inc.
$196
Bayer HealthCare Pharmaceuticals Inc.
$174
Agiliti Surgical, Inc.
$161
Egalet US Inc
$147
Contura, Inc.
$146
Ferring Pharmaceuticals Inc.
$145
AMAG Pharmaceuticals, Inc.
$142
Dendreon Pharmaceuticals LLC
$132
FEMSelect Inc.
$108
BLUEWIND MEDICAL
$106
Sun Pharmaceutical Industries Inc.
$103
ABBVIE INC.
$90
TOLMAR Pharmaceuticals, Inc.
$82
UroGen Pharma, Inc.
$81
Olympus America Inc.
$76
NeoTract Inc.
$67
Mission Pharmacal Company
$50
Innovation Technologies Inc
$48
Merck Sharp & Dohme LLC
$47
Duchesnay USA Incorporated
$34
Myovant Sciences Inc.
$34
Invuity, Inc.
$28
BOSTON SCIENTIFIC CORPORATION
$27
AstraZeneca Pharmaceuticals LP
$26
Merck Sharp & Dohme Corporation
$26
Allergan Inc.
$24
Travere Therapeutics, Inc.
$24
Covidien LP
$24
PFIZER INC.
$24
Avadel Specialty Pharmaceuticals, LLC
$24
UROGEN PHARMA, INC.
$23
Synergy Pharmaceuticals Inc
$20
Retrophin, Inc.
$19
GENZYME CORPORATION
$18
Zyla Life Sciences
$17
Endo Pharmaceuticals Inc.
$16
Photocure Inc
$16
Allergan, Inc.
$15
Novartis Pharmaceuticals Corporation
$15
Antares Pharma, Inc.
$13
J&R Medical, LLC
$12
Top 3 companies account for 68.7% of total payments
Associated products mentioned in payments ›
(815) Thiola · ADVANTAGE FIT · AFINITOR · ALTIS · AXIS · Axonics · Axonics r-SNM System · BOTOX · BRIDION · Bulkamid · CLENPIQ · CYSVIEW · Desara · ELIGARD · ENPLACE · ERLEADA · FIRMAGON · GENERAL ERECTILE DYSFUNCTION · GENERAL BPH · GENERAL FEMALE SUI · GENERAL FEMALE SUI · GENTLECATH · INTERSTIM · INTERSTIM ICON · INTRAROSA · IRRISEPT · JELMYTO · JEVTANA · KEYTRUDA · Kerecis Omega3 SurgiClose · LUPRON DEPOT · LYNPARZA · LithoVue · MYRBETRIQ · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · OXAYDO · Olympus Cysto-Resection · Osphena · PREMARIN ORALS · PROVENGE · Photonblade · SOLYX BLUE · SPRIX · Titan · Trulance · UPSYLON · Uribel · UroLift · XIAFLEX · XTANDI · Xofigo · YONSA · eCoin Device Kit · iDrive · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (50%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for urology physician in TX.

Equivalent to $388 per 100 Medicare services performed
Looking for a urology physician in Arlington?
Compare urology physicians in the Arlington area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
144
Per 100K population
6.7
County median income
$81,905
Nearest hospital
USMD HOSPITAL AT ARLINGTON L P
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Cannon-Smith is a mixed practice specialist, with above-average Medicare volume (top 14% in TX), and high industry engagement (mixed engagement, top 9%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Cannon-Smith experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Cannon-Smith performed 2,800 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cannon-Smith receive payments from pharmaceutical companies?
Yes. Dr. Cannon-Smith received a total of $29,165 from 52 companies across 325 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cannon-Smith's costs compare to other urology physicians in Arlington?
Dr. Cannon-Smith's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cannon-Smith) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →